MedTrace Logo

Hydrogen Gas for Cancer Rehabilitation

NCT03818347 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-10-19

No results posted yet for this study

Summary

The aim of this study is the efficacy of hydrogen gas immunotherapy to rehabilitation and prognosis of cancer patients.

Conditions

  • Adult Solid Tumor

Interventions

DEVICE

oxyhydrogen generator (AMS-H-03)

Rated gas output (L) : 3L/min, concentration of hydrogen and the oxygen was 66.6% and 33.3%, respectively. The patients inhale 3 hours each day through a cannula or mask, and persist for long term

DEVICE

analogue machine

This machine has the same apperance and gas condition

Sponsors & Collaborators

  • Shanghai Asclepius Meditech Co., Ltd

    collaborator UNKNOWN

  • Fuda Cancer Hospital, Guangzhou

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-02
Primary Completion
2020-06-20
Completion
2020-08-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03818347 on ClinicalTrials.gov